NEUROCENTRX PHARMA LIMITED
Company number SC454814 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£5,376,020
Balance sheet as at 2025-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2013-07-18
- Employees
- 1 (2025 accounts)
- Registered office
- Level 5, 9 Haymarket Square, Edinburgh, Scotland, EH3 8RY
- Postcode
- EH3 8RY
- Capital
- 80 GBP
- Accounts category
- Total Exemption Full
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-05-21
- Next due by
- 2027-06-04
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 4 current · 8 resigned
Graeme DUNCAN
Director
MFMAC SECRETARIES LIMITED
Corporate Secretary · corporate
MR Fraser Stuart LUSTY
Director
DR Ronald Mcnaught, Dr LINDSAY
Director
Contact details
- Website
- neurocentrx.com
Neurocentrx is a specialty pharma company, developing and in-licensing products in pain, palliative care, psychiatry and mood disorders.
Previous registered addresses 1
| Address | Changed on |
|---|---|
| 5TH FLOOR, 125 PRINCES STREET, EDINBURGH, EH2 4AD | 2017-05-31 |
Competitors Edinburgh
This company ranks 66 among research and experimental development on biotechnology in Edinburgh.
The class of 2013
32%
of the 312 companies in this sector incorporated in 2013 are still active today; 63% have since been dissolved.
A fact about the year, not a forecast for this company.